Inhibitory activity of 9-phenylcyclohepta[d]pyrimidinedione derivatives against different strains of HIV-1 as non-nucleoside reverse transcriptase inhibitors

Virology Journal

Volumn 8, Issue , 2011, Pages

  Huang, Yang ^a   Wang, Xiaowei ^b   Yu, Xiaoling ^a   Yuan, Lin ^a   Guo, Ying ^b   Xu, Weisi ^a   Liu, Tiejun ^a   Liu, Junyi ^b   Shao, Yiming ^a   Ma, Liying ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1 (ETHOXYMETHYL) 9 PHENYL CYCLOHEPTA[D]PYRIMIDINEDIONE; 1 [(BENZYLOXY)METHYL] 9 PHENYL CYCLOHEPTA[D]PYRIMIDINEDIONE; 1 ALLYL 9 PHENYL CYCLOHEPTA[D]PYRIMIDINEDIONE; 1 BENZYL 9 PHENYL CYCLOHEPTA[D]PYRIMIDINEDIONE; ENFUVIRTIDE; NEVIRAPINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PYRIMIDINE DERIVATIVE; RNA DIRECTED DNA POLYMERASE; TNK 651; UNCLASSIFIED DRUG; 9 PHENYLCYCLOHEPTA(D)PYRIMIDINE 2,4 DIONE; 9-PHENYLCYCLOHEPTA(D)PYRIMIDINE-2,4-DIONE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CYCLOHEPTANE DERIVATIVE; PYRIMIDINONE DERIVATIVE; REVERSE TRANSCRIPTASE, HUMAN IMMUNODEFICIENCY VIRUS 1; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ANTIVIRAL ACTIVITY; ARTICLE; CHINA; CONTROLLED STUDY; CYTOTOXICITY; DRUG DESIGN; DRUG STRUCTURE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IC 50; PERIPHERAL BLOOD MONONUCLEAR CELL; VIRUS INHIBITION; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS STRAIN; CELL LINE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; MICROBIOLOGICAL EXAMINATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ANTI-HIV AGENTS; CELL LINE; CYCLOHEPTANES; HIV REVERSE TRANSCRIPTASE; HIV-1; HUMANS; INHIBITORY CONCENTRATION 50; MICROBIAL SENSITIVITY TESTS; PYRIMIDINONES; REVERSE TRANSCRIPTASE INHIBITORS; VIRUS REPLICATION;

EID: 79955829103     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-230     Document Type: Article

References (14)

1. HIV-1 reverse transcription: a brief overview focused on structure-function relationships among molecules involved in initiation of the reaction. M Gotte X Li MA Wainberg, Arch Biochem Biophys 1999 365 2 199 210 10.1006/abbi.1999.1209 10328813 (Pubitemid 29391627)
2. HIV-1 reverse transcriptase: a therapeutical target in the spotlight. HC Castro NI Loureiro M Pujol-Luz AM Souza MG Albuquerque DO Santos LM Cabral IC Frugulhetti CR Rodrigues, Curr Med Chem 2006 13 3 313 324 10.2174/ 092986706775476089 16475939
3. New targets for inhibitors of HIV-1 replication. JP Moore M Stevenson, Nat Rev Mol Cell Biol 2000 1 1 40 49 11413488
4. Antiviral activity of MK-4965, a novel nonnucleoside reverse transcriptase inhibitor. MT Lai V Munshi S Touch RM Tynebor TJ Tucker PM McKenna TM Williams DJ DiStefano DJ Hazuda MD Miller, Antimicrob Agents Chemother 2009 53 6 2424 2431 10.1128/AAC.01559-08 19289522
5. Antiviral activity of GW678248, a novel benzophenone nonnucleoside reverse transcriptase inhibitor. RG Ferris RJ Hazen GB Roberts MH St Clair JH Chan KR Romines GA Freeman JH Tidwell LT Schaller JR Cowan SA Short KL Weaver DW Selleseth KR Moniri LR Boone, Antimicrob Agents Chemother 2005 49 10 4046 4051 10.1128/AAC.49.10.4046-4051.2005 16189079 (Pubitemid 41400945)
6. The prevalence of transmitted antiretroviral drug resistance in treatment-naive HIV-infected individuals in China. L Liao H Xing H Shang J Li P Zhong L Kang H Cheng X Si S Jiang X Li Y Shao, J Acquir Immune Defic Syndr 53 Suppl 1 10 14
7. Genotypic and Phenotypic Cross-Drug Resistance of Harboring Drug-Resistant HIV Type 1 Subtype B' Strains from Former Blood Donors in Central Chinese Provinces. L Ma J Huang H Xing L Yuan X Yu J Sun Y Huang S Qu Y Feng L Liao S Liu Y Shao, AIDS Res Hum Retroviruses 26 9 1007 13
8. Genotype and phenotype patterns of drug-resistant HIV-1 subtype B' (Thai B) isolated from patients failing antiretroviral therapy in China. L Ma J Sun H Xing X Si L Yuan Y Guo H Cheng Y Shao, J Acquir Immune Defic Syndr 2007 44 1 14 19 10.1097/01.qai.0000243049.27580.cc 17019361 (Pubitemid 46052215)
9. Structural mechanisms of drug resistance for mutations at codons 181 and 188 in HIV-1 reverse transcriptase and the improved resilience of second generation non-nucleoside inhibitors. J Ren C Nichols L Bird P Chamberlain K Weaver S Short DI Stuart DK Stammers, J Mol Biol 2001 312 4 795 805 10.1006/jmbi.2001.4988 11575933 (Pubitemid 33116741)
10. N-substituted pyrrole derivatives as novel human immunodeficiency virus type 1 entry inhibitors that interfere with the gp41 six-helix bundle formation and block virus fusion. S Jiang H Lu S Liu Q Zhao Y He AK Debnath, Antimicrob Agents Chemother 2004 48 11 4349 4359 10.1128/AAC.48.11.4349-4359.2004 15504864 (Pubitemid 39434898)
11. Characterization of a virtually full-length human immunodeficiency virus type 1 genome of a prevalent intersubtype (C/B') recombinant strain in China. L Su M Graf Y Zhang H von Briesen H Xing J Kostler H Melzl H Wolf Y Shao R Wagner, J Virol 2000 74 23 11367 11376 10.1128/JVI.74.23.11367-11376.2000 11070037 (Pubitemid 32224007)
12. Type C virus particles produced in human T-cell lines derived from acute lymphoblastic leukemia and a leukemic T-lymphoid malignancy. T Oda S Watanabe T Nakamura, Acta Med Okayama 1983 37 6 529 533 6198871 (Pubitemid 14103399)
13. Phenotypic and genotypic characterization of human immunodeficiency virus type 1 CRF07-BC strains circulating in the Xinjiang Province of China. L Ma Y Guo L Yuan Y Huang J Sun S Qu X Yu Z Meng X He S Jiang Y Shao, Retrovirology 2009 6 45 10.1186/1742-4690-6-45 19442296
14. Study on evaluation of human immunodeficiency virus reverse transcriptase inhibitor by ELISA. WX Guo Ying Xu Yang Lv Xiao Wang Ruiping Liu Junyi, JOURNAL OF PEKING UN IVERSITY(HEALTH SCIENCES) 2007 39 5 5